Q2 2017 Holdings
Filed 2017-08-11 | 46 holdings | $406.2K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $52.4K | 4,087,264 | 12.9% |
| Express Scripts Hldg Co | COM | 30219G108 | $40.9K | 641,301 | 10.1% |
| Mylan N V | SHS EURO | N59465109 | $35.2K | 907,100 | 8.7% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $34.5K | 749,200 | 8.5% |
| Lilly ELI & Co(LLY) | COM | 532457108 | $34.2K | 415,200 | 8.4% |
| Anthem Inc(ELV) | COM | 036752103 | $27.2K | 144,350 | 6.7% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $26.5K | 373,800 | 6.5% |
| Abbott Labs(ABT) | COM | 002824100 | $21.9K | 450,700 | 5.4% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $20.6K | 391,400 | 5.1% |
| CVS Health Corp(CVS) | COM | 126650100 | $18.2K | 226,600 | 4.5% |
| Davita Inc(DVA) | COM | 23918K108 | $16.8K | 258,800 | 4.1% |
| Forward Pharma A/S | SPONSORED ADR | 34986J105 | $13.3K | 652,500 | 3.3% |
| Neuroderm LTD | ORD SHS | M74231107 | $10.7K | 357,400 | 2.6% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $9.7K | 969,300 | 2.4% |
| Lifepoint Health Inc | COM | 53219L109 | $9.0K | 133,700 | 2.2% |
| Alder Biopharmaceuticals Inc(ALDR1EUR) | COM | 014339105 | $6.4K | 557,770 | 1.6% |
| Corium Intl Inc | COM | 21887L107 | $6.0K | 803,766 | 1.5% |
| Concert Pharmaceuticals Inc(CNCEEUR) | COM | 206022105 | $5.8K | 412,145 | 1.4% |
| Achillion Pharmaceuticals in(ACHNEUR) | COM | 00448Q201 | $5.0K | 1,082,100 | 1.2% |
| Retrophin Inc | COM | 761299106 | $4.8K | 246,289 | 1.2% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $3.1K | 273,500 | 0.8% |
| Foamix Pharmaceuticals LTD | SHS | M46135105 | $2.6K | 569,197 | 0.7% |
| Inotek Pharmaceuticals Corp | COM | 45780V102 | $1.6K | 843,722 | 0.4% |